CVR: 36036869
DKK 7,915,337
Gross profit
Net result: DKK 894,729
Clinical-Microbiomics A/S
CVR · view ownership and management
Owner registered: Clinical-Microbiomics A/S
CVR · 01/03/2024
View the full event history
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.
Source: annual report 2025, Danish Business Authority
The financial health of DNASENSE ApS shows a positive trajectory, particularly in gross profit and profitability over recent years. Gross profit increased from 1,445,856 DKK in 2020 to 7,915,337 DKK in 2025, while profit rose from a loss of 1,081,586 DKK in 2020 to a profit of 894,729 DKK in 2025. Equity has improved significantly, climbing from -92,909 DKK in 2020 to 1,639,012 DKK in 2025, indicating a recovery from previous deficits. However, the absence of revenue figures raises concerns about the sustainability of this growth, and the company remains relatively small within the research and experimental development sector.
AI-generated summary · Generated 13/08/2026
Selskabets formål er konsulent- og analysearbejde inden for DNA sekventering og mikrobiologi og hermed efter ledelsens skøn beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 7.9 mio. | 895 t. | 10.4 mio. | 1.6 mio. | 7 | |
| 202301/10/2022 – 30/09/2023 | 4.5 mio. | 550 t. | 2.2 mio. | 802 t. | 7 | |
| 202201/10/2021 – 30/09/2022 | 4.3 mio. | 867 t. | 2.8 mio. | 852 t. | 6 | |
| 202101/10/2020 – 30/09/2021 | 3 mio. | 78 t. | 1.2 mio. | -15 t. | 5 | |
| 202001/10/2019 – 30/09/2020 | 1.4 mio. | -1.1 mio. | 871 t. | -93 t. | 5 | |
| 201901/10/2018 – 30/09/2019 | 3.4 mio. | 679 t. | 2.1 mio. | 1.3 mio. | 4 | |
| 201801/10/2017 – 30/09/2018 | 2.3 mio. | 524 t. | 1.6 mio. | 910 t. | 2 | |
| 201701/10/2016 – 30/09/2017 | 1.8 mio. | 673 t. | 1.2 mio. | 886 t. | 1 | |
| 201601/10/2015 – 30/09/2016 | 1.1 mio. | 359 t. | 877 t. | 513 t. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningDNASENSE ApS was founded on 3 July 2014.
DNASENSE ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
DNASENSE ApS had 15 employees in 2018 according to the Danish CVR register.
DNASENSE ApS is owned by Clinical-Microbiomics A/S.
dnasense.dk belongs to DNASENSE ApS, CVR number 36036869.
In 2025, DNASENSE ApS reported a gross profit of DKK 7,915,337.
Claim this page to add your logo and social links. Free to get started.
DNASENSE ApS has published its annual report for 2025. Gross profit came to DKK 7,915,337, and the net result was DKK 894,729.
DNASENSE ApS has published its interim report for the period October 1, 2023 – December 31, 2024.
As of February 19, 2025, Anders Mohr Christensen has joined the board of directors of DNASENSE ApS.
As of November 27, 2024, Manoj Nirmal Dadlani has joined the board of directors of DNASENSE ApS.
As of November 27, 2024, Henrik Knudsen has left the board of directors of DNASENSE ApS.
As of March 12, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of DNASENSE ApS.
As of March 12, 2024, Henrik Knudsen has joined the board of directors of DNASENSE ApS.
As of March 12, 2024, Anders Christian Neto de Sousa Grøn has joined the board of directors of DNASENSE ApS.
As of March 12, 2024, Henrik Bjørn Nielsen has joined the board of directors of DNASENSE ApS.
As of March 1, 2024, Clinical-Microbiomics A/S is registered as an owner of DNASENSE ApS with an ownership share of 100%.
DNASENSE ApS has published its annual report for 2023. Gross profit came to DKK 4,532,635, and the net result was DKK 549,847.
DNASENSE ApS has published its annual report for 2022. Gross profit came to DKK 4,258,224, and the net result was DKK 866,938.
DNASENSE ApS has published its annual report for 2021. Gross profit came to DKK 3,039,679, and the net result was DKK 77,939.
DNASENSE ApS has published its annual report for 2020. Gross profit came to DKK 1,445,856, and the net result was DKK -1,081,586.
As of July 1, 2020, Mads Toft Søndergaard is registered as director of DNASENSE ApS.
As of July 1, 2020, Mads Albertsen has stepped down as director of DNASENSE ApS.
DNASENSE ApS has published its annual report for 2019. Gross profit came to DKK 3,379,904, and the net result was DKK 678,650.
DNASENSE ApS has published its annual report for 2018. Gross profit came to DKK 2,296,217, and the net result was DKK 524,124.
DNASENSE ApS has published its annual report for 2017. Gross profit came to DKK 1,796,466, and the net result was DKK 673,206.
DNASENSE ApS has published its annual report for 2016. Gross profit came to DKK 1,123,634, and the net result was DKK 359,058.
DNASENSE ApS has published its interim report for the period July 3, 2014 – September 30, 2015.
As of July 3, 2014, Mads Albertsen is registered as director of DNASENSE ApS.
DNASENSE ApS was founded on July 3, 2014.
Companies in the same industry and area
CVR 33864884
CVR 38322761
CVR 39606925
CVR 40237216
CVR 41458534
